Rafferty Asset Management’s ArriVent BioPharma AVBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$343K Sell
15,749
-1,660
-10% -$36.1K ﹤0.01% 955
2025
Q1
$322K Sell
17,409
-9,890
-36% -$183K ﹤0.01% 946
2024
Q4
$727K Buy
27,299
+17,763
+186% +$473K ﹤0.01% 847
2024
Q3
$224K Buy
+9,536
New +$224K ﹤0.01% 1083